{"disease":{"id":"htlv-1","name":"htlv 1"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03226119","title":"MP Diagnostics HTLV Blot 2.4 Post-Market Clinical Study","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":150,"lead_sponsor_name":"MP Biomedicals, LLC","has_results":false},{"nct_id":"NCT03146013","title":"Dual Algorithm Post Market Clinical Study","phase":"","overall_status":"COMPLETED","enrollment_count":100,"lead_sponsor_name":"MP Biomedicals, LLC","has_results":false},{"nct_id":"NCT03191526","title":"A Study of KW-0761 in Subjects With HTLV-1 Associated Myelopathy (HAM)","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":66,"lead_sponsor_name":"Kyowa Kirin Co., Ltd.","has_results":false},{"nct_id":"NCT02877030","title":"Sensorimotor Exercises in Virtual Reality Platform in Individuals With Human T-lymphotropic Virus","phase":"NA","overall_status":"COMPLETED","enrollment_count":42,"lead_sponsor_name":"Pedreira, Érika, M.D.","has_results":false},{"nct_id":"NCT06616675","title":"Darifenacin x Parasacral Transcutaneous Electric Nerve Stimulation for OAB in Patients Infected With Human T-Lymphotropic Virus 1","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":42,"lead_sponsor_name":"Hospital Universitário Professor Edgard Santos","has_results":false},{"nct_id":"NCT04301076","title":"Testing the Addition of an Anti-cancer Drug, Lenalidomide, to the Usual Combination Chemotherapy Treatment (\"EPOCH\") for Adult T-Cell Leukemia-Lymphoma (ATLL)","phase":"PHASE1","overall_status":"SUSPENDED","enrollment_count":30,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":false},{"nct_id":"NCT04830319","title":"Pilates Method in People With HAM/TSP","phase":"NA","overall_status":"COMPLETED","enrollment_count":22,"lead_sponsor_name":"Pedreira, Érika, M.D.","has_results":false},{"nct_id":"NCT01651819","title":"Urological Physical Therapy in HTLV-1 With Urinary Symptoms","phase":"NA","overall_status":"COMPLETED","enrollment_count":20,"lead_sponsor_name":"Hospital Universitário Professor Edgard Santos","has_results":false},{"nct_id":"NCT05240612","title":"A Clinical Pharmacological Study of MT-3921 in Subjects With HTLV-1 Associated Myelopathy (HAM)","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":15,"lead_sponsor_name":"Tanabe Pharma Corporation","has_results":false},{"nct_id":"NCT03075553","title":"Nivolumab in Treating Patients With Relapsed or Refractory Peripheral T-cell Lymphoma","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":12,"lead_sponsor_name":"Mayo Clinic","has_results":true},{"nct_id":"NCT00076843","title":"Hu Mik-Beta-1 to Treat HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":9,"lead_sponsor_name":"National Institute of Neurological Disorders and Stroke (NINDS)","has_results":false},{"nct_id":"NCT02631746","title":"Nivolumab in Treating Patients With HTLV-Associated T-Cell Leukemia/Lymphoma","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":3,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":true}],"total":12},"guidelines":[],"source":"Drug Landscape verified database"}